During the past decade, INTERCORE Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
2023-02-03
2025-01-08
Recruiting
432
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "INTERCORE Medical Center"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at INTERCORE Medical Center
According to Clinical.Site data, the most researched conditions in "INTERCORE Medical Center" are
"Heart Failure" (3 trials), "Advanced Breast Cancer" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Dyslipidemias" (1 trials) and "Familial Hypercholesterolemia" (1 trials). Many other conditions were trialed in "INTERCORE Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at INTERCORE Medical Center
Most popular intervention types in "INTERCORE Medical Center" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (3 trials), "BI 456906" (1 trials), "BI 690517" (1 trials) and "Chemotherapy Drugs, Cancer" (1 trials). Other intervention names were less common.
Clinical Trials Genders at INTERCORE Medical Center
The vast majority of trials in "INTERCORE Medical Center" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at INTERCORE Medical Center
Currently, there are NaN active trials in "INTERCORE Medical Center".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in INTERCORE Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in INTERCORE Medical Center, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".